Get the app
US › Healthcare

biote Corp (BTMD)

US · Healthcare · Medical Care Facilities

$1.35+0.75%
Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue
$44.2M
Revenue YoY
-9.5%
Net profit
$-6.6M
Profit YoY
-306.1%
EPS
$0.10
EPS estimate
$0.03
Net margin
-14.8%

EPS came in at 0.10 against a street estimate of 0.03 — a beat of 233.3%.

Key statistics

Market cap
$45.1M
P/E
9.5
Forward P/E
5.2
P/B
2.96
Book value
$-2.38
EPS (TTM)
$0.14
52-week high
$3.52
52-week low
$1.27
50-day MA
$1.88
200-day MA
$2.08
Beta
1.61

Analyst view

Analysts rate biote Corp a strong buy (6 buy, 0 hold, 0 sell out of 6) with an average price target of $2.61.

Shareholding

Insiders
19.06%
Institutions
63.04%

Largest institutional holders

FundStake
325 Capital LLC15.86%
Bandera Partners LLC7.20%
BlackRock Inc6.06%
Vanguard Capital Management, LLC3.88%
Acadian Asset Management LLC2.43%
State Street Corp2.26%
Geode Capital Management, LLC2.15%
Millennium Management LLC1.52%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for biote Corp — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncMerck & Company IncUnitedHealth Group IncorporatedNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncAmgen IncNovo Nordisk A/SGilead Sciences IncAbbott Laboratories

Data updated 2026-09-18.